Skip to main content

Editorial Board

EDITORS-IN-CHIEF

Lucia Altucci

New Content ItemUniversità degli Studi della Campania Luigi Vanvitelli, Italy

Research website

ORCID profile

Twitter: @LuciaAltucci

Specialisms: Epigenetics, Cancer, Programmed cell death, Signal transduction, Innovative therapies
 

Marianne Rots

New Content ItemUniversity Medical Center Groningen, The Netherlands 

Research website

ORCID profile

Specialisms: Epigenetics, Epigenetic editing

ADVISORY BOARD

Caroline Relton

New Content ItemUniversity of Bristol, United Kingdom

Research website

ORCID profile

Twitter: @carolinerelton

Specialisms: Epigenetics, Epidemiology

Rui Henrique, Portuguese Oncology Institute of Porto and Institute of Biomedical Sciences Abel Salazar, University of Porto, Portugal

Holger Heyn, National Center for Genomic Analysis, Center for Genomic Regulation (CNAG-CRG), Barcelona Institute of Science and Technology (BIST), Spain

Hendrik (Henk) G Stunnenberg, Princess Máxima Center for Pediatric Oncology, Utrecht and Radboud University Nijmegen, The Netherlands

SECTION EDITORS

Paola Arimondo

New Content ItemCNRS - Institut Pasteur, France

Research website

ORCID profile

Twitter: @PbaEpiCBio1

Section: Epigenetic therapies and clinical trials

Specialisms: Chemical biology, Epigenetics, DNA, Histone

Sam El-Osta

New Content ItemMonash University, Australia

Research website

ORCID profile

Twitter: @SamElOsta1

Section: Endocrinology and metabolic epigenetics

Specialisms: Epigenetics, DNA methylation, Chromatin, Histones, Gene Regulation, Human Disease, Cardiovascular Disease, T1D
 

Steven Gray

New Content ItemSt James's Hospital, Ireland

Research website

ORCID profile
 

Section: Environmental epigenetics

Specialisms: Lung Cancer, Mesothelioma, Biomarker, Epigenetics

John Holloway

New Content ItemUniversity of Southampton, United Kingdom

Research website

ORCID profile

Twitter: @ProfJWHolloway

Section: Respiratory Epigenetics

Specialisms: Asthma, Allergy, Respiratory, Genomics, Epigenetics
 

Carmen Jerónimo

New Content ItemUniversity of Porto, Portugal 

Research website

ORCID profile
 

Twitter: @GEBC_IPOPorto

Section: Cancer epigenetics and diagnostics

Specialisms: Cancer Epigenetics, Cancer epitranscriptomics, Biomarkers, Epidrugs, Molecular pathology, Precision oncology
 

Tomasz K Wojdacz

New Content ItemPomeranian Medical University in Szczecin, Poland

Research website

ORCID profile
 

Section: Epigenetic biomarkers

Specialisms: Epigenetics, Methylation, Cancer, Biomarker, diagnosis, IVD 

Maria Berdasco, Joseph Carreras Leukemia Research Institute (IJC), Spain
Section: Cancer epigenetics and diagnostics

Jim Davie, University of Manitoba, Canada
Section: Epigenetic technologies

Georges Herbein, University of Franche-Comté, France
Section: Allergy, immunology, pathogens and inflammation

Jonathan Licht, The University of Florida, USA
Section: Cancer Epigenetics – Haematological Malignancies

Eamonn Maher, University of Cambridge, UK
Section: Reproductive and transgenerational epigenetics

Jonathan Mill, University of Exeter and King's College London, UK
Section: Neurology and psychiatry epigenetics

Adele Murrell, University of Bath, UK
Section: Regenerative medicine

Ronan Murphy, Dublin City University, Ireland
Section: Cardiovascular epigenetics

Moshe Szyf, McGill University, Canada
Section: Neurology and psychiatry epigenetics

Akihiro Umezawa, National Institute for Child Health & Development, Japan
Section: Aging and development epigenetics
 

ASSOCIATE EDITORS

Nita Ahuja, Yale University, USA
Section:
Cancer epigenetics and diagnostics

Miguel Constancia, University of Cambridge, UK
Section: Reproductive and transgenerational epigenetics

Dawn L. DeMeo, Brigham and Women's Hospital/ Harvard Medical School, USA
Section: Respiratory Epigenetics

James M Flanagan, Imperial College London, UK
Section:
Cancer epigenetics and diagnostics

Mario F Fraga, Nanomaterials and Nanotechnology Center (CINN-CSIC), Health Research Institute of Asturias (ISPSA), Institute of Oncology of Asturias (IUOPA, University of Oviedo), Spain
Section:
Cancer epigenetics and diagnostics

Michèle J Hoffmann, Heinrich-Heine-University Duesseldorf, Germany
Section:
Cancer epigenetics and diagnostics

Albert Jeltsch, University of Stuttgart, Germany 
Section: Epigenetic technologies

Bozena Kaminska, Nencki Institute of Experimental Biology, Poland
Section:
Cancer epigenetics and diagnostics

Nishino Koichiro, University of Miyazaki, Japan
Section: Aging and development epigenetics

Nick La Thangue, University of Oxford, UK
Section:
Epigenetic therapies and clinical trials

Charlotte Ling, Lund University, Sweden
Section: Endocrinology and metabolic epigenetics

Gwen Lomberk, Medical College of Wisconsin, USA
Section:
Cancer epigenetics and diagnostics

Lingeng Lu, Yale University, USA
Section:
Statisticians

Antonello Mai, "Sapienza" Universitá di Roma, Italy
Section:
Epigenetic therapies and clinical trials

Riccardo Marioni, University of Edinburgh, UK
Section: Neurology and psychiatry epigenetics

Joost Martens, Radboud Institute for Molecular Life Sciences, The Netherlands
Section:
Cancer Epigenetics – Haematological Malignancies

Richard Momparler, University of Montreal, Canada
Section:
Epigenetic therapies and clinical trials

Kari Nadeau, Stanford University, USA
Section:
Allergy, immunology, pathogens and inflammation

Boris Novakovic, Murdoch Children's Research Institute, Australia
Section:
Environmental epigenetics

Arpad Patai, Semmelweis University, Hungary
Section:
Cancer epigenetics and diagnostics

Monika Puzianowska-Kuznicka, Mossakowski Medical Research Centre, Poland
Section: Aging and development epigenetics

Peter Rugg-Gunn, The Babraham Institute, University of Cambridge, UK
Section: Regenerative medicine

Richard Saffery, Murdoch Children’s Research Institute, Australia
Section:
Endocrinology and metabolic epigenetics

David Jay Segal, University of California-Davis, USA
Section:
Innovative epigenetic therapies

Harold Snieder, University Medical Center Groningen, The Netherlands
Section:
Epigenetic biomarkers, Statisticians

Qian Tao, The Chinese University of Hong Kong, Hong Kong
Section:
Cancer epigenetics and diagnostics

Andrew Teschendorff, Chinese Academy of Sciences and Max-Planck Partner Institute for Computational Biology, CAS, China
Section:
Epigenetic biomarkers

Jonathan Turner, Luxembourg Institute of Health, Luxembourg
Section: Neurology and psychiatry epigenetics

Raul Urrutia, Genomics Sciences and Precision Medicine Center, Medical College of Wisconsin, USA 
Section: Cancer epigenetics and diagnostics

Saad Z Usmani, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Section:
Cancer Epigenetics – Haematological Malignancies

Wim Vanden Berghe, University of Antwerp, Belgium
Section:
Lifestyle epigenetics

Wolfgang Wagner, Aachen University Medical School, Germany
Section: Agin

Stefan Wiemann, German Cancer Research Center-Heidelberg (DKFZ), Germany
Section:
Cancer epigenetics and diagnostics

Keishi Yamashita, Kitasato University, Japan
Section:
Cancer epigenetics and diagnostics
 

EDITORIAL BOARD

Lorena Aguilar Arnal, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, México
Alfonso Baldi, Università della Campania Luigi Vanvitelli, Italy
Steven Belinsky, Lovelace Respiratory Research Institute, USA
Rosaria Benedetti, Universitá degli Studi della Campania "Luigi Vanvitelli", Italy
Nathalie Bérubé, Western University, Canada
Pilar Blancafort, The Harry Perkins Institute of Medical Research & University of Western Australia, Australia
Tiziana Bonaldi, European Institute of Oncology, Italy 
Miguel Branco, Queen Mary University of London, UK
Robert Brown, Imperial College London, UK
Kyle J Burghardt, Wayne State University, USA
Andres Cardenas, University of California, Berkeley, USA
Katherine Chiappinelli, George Washington University, USA
James Chim, University of Hong Kong, Hong Kong
Gianluigi Condorelli, Humanitas University, Italy
Rene Cortese, University of Missouri, USA
Christos Damaskos, University of Athens, Greece
Soner Dogan, Yeditepe University, Turkey
Thomas Eggermann, RWTH Aachen, Germany
Karl Ekwall, Karolinska Institutet, Sweden
Frank O Fackelmayer, Institute of Molecular Biology and Biotechnology IMBB-Forth, Greece
Mirco Fanelli, University of Urbino "Carlo Bo," Italy
Robert Feil, CNRS and University of Montpellier, France
Roger Foo, Genome Institute of Singapore, Singapore
François Fuks, Université libre de Bruxelles, Belgium
Peter Gluckman, The Liggins Institute of Medical Research, New Zealand
Antonio Gómez, University of Vic – Central University of Catalonia, Spain
Joel Gottesfeld, The Scripps Research Institute, USA
Monika Hegi, Lausanne University Hospital, Switzerland
Ricky Johnstone, Peter MacCallum Cancer Centre, Australia
Meaghan Jones, The University of British Columbia, Canada
Renata Jurkowska, Cardiff University, UK
Masayo Kagami, National Research Institute for Child Health and Development, Japan
Yutaka Kondo, Nagoya City University Graduate School of Medical Sciences, Japan
Ah-Ng Tony Kong, Rutgers University, USA
Michele A La Merrill, University of California-Davis, USA
Andy Lau, Shantou University Medical College, China
Haitao Li, Tsinghua University, China
Lili Li, The Chinese University of Hong Kong, Hong Kong
Michael Lübbert, Universitätsklinikum Freiburg, Germany
Deborah JG Mackay, Southampton University Hospital, UK
Patrick O McGowan, University of Toronto, Canada
Saverio Minucci, IFOM - IEO, Italy
David Monk, Institut d'Investigació Biomèdica Bellvitge, Spain
Pamela Munster, University of California, USA
Clara Nervi, University of Rome La Sapienza, Italy
Andreas Neubauer, Philipps Universität Marburg, Germany
Stephen Nimer, University of Miami, USA
Miina Ollikainen, University of Helsinki, Finland
Jan Postberg, Witten/Herdecke University, Germany
H Llewelyn Roderick, KU Leuven, Belgium
Olivier Rohr, University of Strasbourg, France
Lucas A Salas, Geisel School of Medicine at Dartmouth College, USA
Paola Scaffidi, The Francis Crick Institute and UCL Cancer Institute, UK
Huidong Shi, Georgia Cancer Center, Medical College of Georgia, Augusta University, USA
Toshihiro Shioda, Massachusetts General Hospital Center for Cancer Research and Harvard Medical School, USA
Gustavo Turecki, McGill University, Canada
Toshikazu Ushijima, National Cancer Center Research Institute, Japan
Carine Van Lint, University of Brussels (ULB), Belgium
Eric Verdin, J David Gladstone Institutes, USA
Aleksandar Vojta, University of Zagreb, Croatia
Bea Wisman, University Medical Center Groningen, The Netherlands
Olaf Witt, German Cancer Research Center, Germany
Suowen Xu, University of Science and Technology of China, China
Elisabeth Zeisberg, University Medical Center Göttingen, Germany
Vlatka Zoldos, University of Zagreb, Croatia